Chemoinformaics analysis of BENZENE, 1-METHYL-4-(2-METHYLPROPYL)-
Molecular Weight | 148.249 | nRot | 2 |
Heavy Atom Molecular Weight | 132.121 | nRig | 6 |
Exact Molecular Weight | 148.125 | nRing | 1 |
Solubility: LogS | -4.707 | nHRing | 0 |
Solubility: LogP | 4.401 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
nHA | 0 | APOL | 29.0387 |
nHD | 0 | BPOL | 16.0513 |
QED | 0.604 |
Synth | 1.323 |
Natural Product Likeliness | -0.405 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.008 |
Pgp-sub | 0.005 |
HIA | 0.003 |
CACO-2 | -4.297 |
MDCK | 0.0000236 |
BBB | 0.861 |
PPB | 0.937237 |
VDSS | 2.17 |
FU | 0.0545349 |
CYP1A2-inh | 0.845 |
CYP1A2-sub | 0.835 |
CYP2c19-inh | 0.924 |
CYP2c19-sub | 0.838 |
CYP2c9-inh | 0.816 |
CYP2c9-sub | 0.913 |
CYP2d6-inh | 0.074 |
CYP2d6-sub | 0.397 |
CYP3a4-inh | 0.103 |
CYP3a4-sub | 0.488 |
CL | 11.955 |
T12 | 0.339 |
hERG | 0.054 |
Ames | 0.015 |
ROA | 0.037 |
SkinSen | 0.294 |
Carcinogencity | 0.477 |
EI | 0.991 |
Respiratory | 0.037 |
NR-Aromatase | 0.004 |
Antiviral | No |
Prediction | 0.796554 |